Clinigen divests global rights to four cancer support therapies to CNX Therapeutics 10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the...